Repligen Corporation - RGEN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Repligen Corporation - SIC # 2836

Ticker	Exchange	SIC #	Website	Latest Ticker
RGEN	Nasdaq	2836	http://www.repligen.com	7.64 -0.28
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Repligen Corporation Why Repligen Is Ready to Rebound - Jun 18th, 2013 7:50 am Nasdaq stocks posting largest percentage increases - May 31st, 2013 4:04 pm Repligen CEO to Present at Jefferies 2013 Global Healthcare Conference - May 23rd, 2013 11:39 am REPLIGEN CORP Financials - May 14th, 2013 11:04 am Repligen Stock Sees Short Interest Move 24.7% Higher - May 10th, 2013 1:34 pm REPLIGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - May 10th, 2013 7:32 am REPLIGEN CORP Files SEC form 10-Q, Quarterly Report - May 7th, 2013 4:56 am Repligen's CEO Discusses Q1 2013 Results - Earnings Call Transcript - May 3rd, 2013 9:55 pm Repligen Reports First Quarter 2013 Financial Results - May 2nd, 2013 1:45 pm Repligen Corporation Earnings Call scheduled for 9:00 am ET today - May 2nd, 2013 7:00 am Repligen Reports First Quarter 2013 Financial Results - May 2nd, 2013 5:30 am Q1 2013 Repligen Corporation Earnings Release - Before Market Open - May 2nd, 2013 5:07 am REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - May 1st, 2013 11:48 pm Incremental Changes in Regulatory Environment Beneficial to Development-Stage Biotech Companies Due to Emphasis on Closer Working Relationships with the FDA and Drug Sponsors - May 1st, 2013 9:32 am Isis Pharma's ISIS-SMNRx Progresses - Apr 24th, 2013 2:40 pm Repligen to Report First Quarter 2013 Financial Results - Apr 23rd, 2013 5:20 pm Repligen to Report First Quarter 2013 Financial Results - Apr 23rd, 2013 3:35 pm Repligen Promises To Be A Cash Flow Machine - Apr 2nd, 2013 1:59 pm REPLIGEN CORP Files SEC form 10-K, Annual Report - Mar 15th, 2013 8:16 am Repligen Management Discusses Q4 2012 Results - Earnings Call Transcript - Mar 7th, 2013 8:50 am View All Current Headlines >>